Cannara Biotech Reports Q2 2024 Financial Results
Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4.0...
Stay updated with breaking news from Distribution Insights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4.0...
Unparalleled, holistic insights created for asset managers and fund boards from combined product and consumer data sets LONDON and NEW YORK, Jan. 11, 2024 /PRNewswire/ -- Boring Money, a financial...
/PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade...
/CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis...
12th annual ranking highlights that investment strategy and solidity distinguish leading asset managers NEW YORK, March 28, 2023 /PRNewswire/ -- The latest edition of Broadridge's Fund Brand 50 ,... | March 28, 2023